Pulmonary Tuberculosis V
Pulmonary Tuberculosis IV
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Jaison Barreto1, Patricia Sammarco Rosa1, Linda Adams1
1From the Research Division, Instituto Lauro de Souza Lima, Bauru (J.B., P.S.R.), and Fundação de Dermatologia Tropical e Venereologia Alfredo da Matta, Manaus (P.F.B.R.) - both in Brazil; the Department of Health and Human Services, Health Resources and Services Administration, Health Systems Bureau, National Hansen's Disease Program, Laboratory Research Branch, Baton Rouge, LA (L.A., R.T.); Translational Medicine and Early Development Statistics (S.Y.), WAVE Team (Z.A., S.R.C., S.K., D.M., J.A.P., M.W.), Janssen Research and Development, San Diego, CA; Janssen Global Public Health, Janssen Research and Development, Titusville, NJ (N.B., R.D.A.); and Janssen Global Public Health, Janssen Pharmaceutica, Beerse, Belgium (E.E., N.L., B.R.).
Bedaquiline monotherapy effectively cleared Mycobacterium leprae in leprosy patients within 4 weeks and improved skin lesions by 7 weeks, offering a potentially safer alternative to standard multidrug therapy.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: